Ignite Creation Date:
2025-12-18 @ 8:22 AM
Ignite Modification Date:
2025-12-18 @ 8:22 AM
Study NCT ID:
NCT00925015
Status:
None
Last Update Posted:
2018-08-15 00:00:00
First Post:
2009-06-17 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase I Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Participants With Colorectal Cancer (MK-0646-016)
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06-17
Start Date Type:
ACTUAL
Primary Completion Date:
2010-07-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-12-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-06-17 00:00:00
First Submit QC Date:
None
Study First Post Date:
2009-06-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-24 00:00:00
Results First Submit QC Date:
None
Results First Post Date:
2017-08-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-18 00:00:00
Last Update Post Date:
2018-08-15 00:00:00
Last Update Post Date Type:
ACTUAL